FDA announces the approval of the first generic of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 micrograms per actuation, for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older.
fda.gov
fda.gov
RSS Hunter
2026-03-03